Axonis Therapeutics

About:

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

Website: https://axonis.us

Twitter/X: axonis_us

Top Investors: Alexandria Venture Investments, MRL Ventures Fund, Perceptive Advisors, Cormorant Asset Management, Sofinnova Investments

Description:

Axonis Therapeutics is a neuro-focused biotechnology company developing medicines targeting KCC2, the critical mediator of inhibition within the brain, by translating breakthrough discoveries from Boston Children’s Hospital, Harvard, and Laval University. It develops a proprietary neuron-specific K-Cl cotransporter (KCC2) discovery engine to improve the lives of people suffering from neurological disorders by fine-tuning inhibition to treat conditions such as epilepsy, pain, and other central nervous system pathologies.